40.3%
of U.S. adults had obesity
Measured among adults age 20 and older during August 2021 through August 2023.
Source: CDC, National Health and Nutrition Examination SurveyAugust 2021-August 2023
U.S. Reference Data
Key U.S. figures for writers, clinic teams, and researchers. Every statistic includes its source and reporting date.
Last updated September 2, 2026
At A Glance
Weight management sits at the intersection of chronic-disease care, access, and documentation. This page brings together recent public data on obesity, diabetes, and GLP-1 medication use in one stable reference. It is informational only and is not medical advice.
Population Data
These figures use national CDC datasets and reporting. Obesity measures in these sources are based on body mass index, which has recognized limitations.
40.3%
Measured among adults age 20 and older during August 2021 through August 2023.
Source: CDC, National Health and Nutrition Examination SurveyAugust 2021-August 2023
72.4%
This is the CDC estimate for adults age 20 and older.
Source: CDC FastStatsAugust 2021-August 2023
9.4%
The unadjusted estimate was highest among adults ages 40 to 59.
Source: CDC, National Health and Nutrition Examination SurveyAugust 2021-August 2023
46.4%
This age group had the highest reported prevalence among the three adult age groups measured.
Source: CDC, National Health and Nutrition Examination SurveyAugust 2021-August 2023
$173B
The CDC reports this estimate in 2019 dollars.
Source: CDC, Consequences of Obesity2019 cost estimate
Care And Access
These figures combine current CDC estimates with KFF survey findings on public use and affordability.
40.1M
The CDC describes this as about 1 in every 8 people.
Source: CDC, A U.S. Report Card: DiabetesUpdated February 11, 2026
115.2M
That is more than 2 in 5 adults.
Source: CDC, A U.S. Report Card: DiabetesUpdated February 11, 2026
8 in 10
This is the CDC estimate reported with its current diabetes statistics.
Source: CDC, A U.S. Report Card: DiabetesUpdated February 11, 2026
18%
The KFF survey includes use for weight loss or chronic conditions such as diabetes or heart disease.
Source: KFF Health Tracking PollNovember 2025
12%
KFF reported this was up from 6% in its May 2024 survey.
Source: KFF Health Tracking PollNovember 2025
56%
This included 55% of users who had health insurance.
Source: KFF Health Tracking PollNovember 2025
Methodology And Sources
Each figure is taken directly from the named source and retains that source's reporting period. CDC figures are drawn from national surveillance and survey reporting. GLP-1 use and affordability figures are self-reported responses from KFF's Health Tracking Poll.
Data is reviewed about monthly, or sooner when a key source publishes a material update. Source links lead to the original publisher so readers can review definitions, methods, and full context.
Apex Lab USA. "U.S. Obesity, Diabetes, and GLP-1 Statistics (2026)." Updated September 2, 2026. https://apexlabusa.com/weight-management-statistics.